These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4585544)

  • 1. [Hyperammoniemia and its treatment].
    Szám I
    Orv Hetil; 1973 Oct; 114(43):2581-9. PubMed ID: 4585544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of hyperammoniemia].
    Nordmann R
    Dtsch Med Wochenschr; 1969 Jan; 94(5):230-1. PubMed ID: 5762228
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient].
    Michel H; Ogé P; Bertrand L
    Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].
    Henglein-Ottermann D
    Ther Ggw; 1976 Sep; 115(9):1504-18. PubMed ID: 968783
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current views on the therapy of hepatic coma].
    Ziegler K
    Z Gesamte Inn Med; 1970 Apr; 25(8):341-3. PubMed ID: 4331690
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
    Müting D
    Clin Ter; 1967 Aug; 42(4):289-97. PubMed ID: 5608820
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent acquisitions on the pathogenesis of hyperammoniemia: clinico-experimental study on a new anti-ammonia drug].
    Furiosi P; Mercati U; Pasquini F
    Minerva Med; 1967 Feb; 58(15):553-63. PubMed ID: 6021622
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of ornithine-ketoglutarate on provoked hyperammonaemia in patients with cirrhosis of the liver (author's transl)].
    Blahíková L; Horký J; Pechar J; Vidlaková M; Zvolánková K; Vosmík J; Marecková O
    Cesk Gastroenterol Vyz; 1978 Jun; 32(4):262-7. PubMed ID: 688420
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current problems in the treatment of hepatic cirrhosis].
    Oancea R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):303-10. PubMed ID: 6173910
    [No Abstract]   [Full Text] [Related]  

  • 10. [Congenital hyperammoniemia caused by ornithine carbamoyl-transferase and carbamyl phosphate synthetase deficiency].
    Salle B; Levin B; Longin B; Richard P; Andre M; Gauthier J
    Arch Fr Pediatr; 1972 May; 29(5):493-504. PubMed ID: 4655647
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
    Szám I; Szentner J; Hegedüs-Wein I; Vass A; Szilárd T
    Wien Med Wochenschr; 1974 May; 124(20):319-25. PubMed ID: 4829691
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperammonemia due to a mutant enzyme of ornithine transcarbamylase.
    Matsuda I; Arashima S; Nambu H; Takekoshi Y; Anakura M
    Pediatrics; 1971 Oct; 48(4):595-600. PubMed ID: 5114747
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prophylaxis and treatment of hyperammoniemia].
    Szám I
    Ther Ggw; 1970 Aug; 109(8):1175 passim. PubMed ID: 5531834
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperammonemia--congenital abnormality of the urea cycle].
    Arashima I
    Saishin Igaku; 1972 Apr; 27(4):730-42. PubMed ID: 5026635
    [No Abstract]   [Full Text] [Related]  

  • 15. [TRIALS OF PROTECTION AGAINST EXPERIMENTAL HYPERAMMONIEMIA].
    BLANPIN O; VALLEE D
    Therapie; 1963; 18():1379-92. PubMed ID: 14117534
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hyperammoniemia. Inborn metabolic disorder of the ornithine cycle. I. Diagnostic problems].
    Vulovic D; Joksimovic I; Subotic Z; Hajdukovic R; Vuckovic M; Levin B; Dobbs R
    Srp Arh Celok Lek; 1973; 101(3):201-16. PubMed ID: 4786871
    [No Abstract]   [Full Text] [Related]  

  • 18. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary orotic acid excretion - a sensitive indicator of ammonia detoxication].
    Rajantie J
    Duodecim; 1981; 97(22):1860-4. PubMed ID: 7343301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biochemical mechanisms of action of catalyzers of ureogenesis and their use in human therapy].
    Salvatore F; Cimino F
    Recenti Prog Med; 1976 Aug; 61(2):179-210. PubMed ID: 1037141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.